CalciMedica, Inc. (CALC) Dividend History

CalciMedica, Inc. is a biotechnology company focused on developing therapies that target calcium signaling pathways involved in inflammatory and immune responses. Their innovative treatments aim to address diseases such as acute respiratory distress syndrome (ARDS), inflammatory bowel disease, and other immune-related conditions. The company leverages cutting-edge research to develop novel solutions to improve patient outcomes.

505 Coast Boulevard South, La Jolla, CA, 92037
Phone: 858-952-5500
Website: https://www.calcimedica.com

Dividend History

CalciMedica, Inc. currently does not pay dividends

Company News

Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?

Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.

Zacks Investment Research

Featured Companies: ALC
CalciMedica And 2 Other Penny Stocks Insiders Are Buying

The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. CalciMedica The Trade: CalciMedica, Inc. (NASDAQ: CALC) Chief Business Officer Eric W Roberts acquired a total of 4,000 shares an average price of $3.90. To acquire these shares, it cost around $15,600. What’s Happening: On March 28, CalciMedica posted a fourth-quarter loss of 23 cents ...

Benzinga

Featured Companies: RCG TGEN
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)

CARPO top-line data expected in 1H2024

GlobeNewswire Inc.

Page data last updated 07/25/2025 03:56:24 UTC